Medicinal products for human use

Responses to the public consultation on the concept paper on the Introduction of Fees for Pharmacovigilance to be charged by the European Medicines Agency

A summary of the responses is available here.

Below are the public responses to the above-mentioned public consultation. The following submitting parties requested their submission not to be published: C. Brady (Austria), Combe International Ltd., Dallas Burston Ashbourne Ltd., Derma UK, Four Pharmaceuticals Ltd. (UK), Greek National Agency Organization (EOF), Romastru Trading SRL, S.A. MITHRA Pharmaceuticals NV and SpePharm Holding BV.

Additional information: